Work

Optimizing elritercept benefit-risk profile by response-based adaptive dosing in patients with low-risk Myelodysplastic Syndromes (LR-MDS)

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-2089

Authors: Christine Neumar, Wenping Wang, Leopold Sellner, Kaveri Suryanarayan, Xiaofei Zhou

Language: English

Topic: Pharmaceutical studies and practices

Subfield: Pediatrics, Perinatology and Child Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417017084

Cites:

Cited by:

Related to: